NYSE:AORTMedical Equipment
How Artivion’s Return To Profitability And Device Demand At Artivion (AORT) Has Changed Its Investment Story
In February 2026, Artivion reported its fourth-quarter and full-year 2025 results, with revenue rising to US$115.99 million for the quarter and US$441.33 million for the year, and net income improving to US$2.43 million and US$9.77 million respectively, reversing prior-year losses.
Beyond the headline return to profitability, management credited strong demand for stent grafts and the On-X mechanical heart valve, supported by fresh clinical data, while acknowledging lingering operational...